Wednesday, October 28, 2009

FDA LAUNCHES HOTLINE FOR DRUG COMPLAINTS OR PROBLEMS

From: DOH Webpage

Press Release/27 October 2009

Any complaints on the drug you’re taking?

The Food and Drug Administration (FDA) of the Department of Health (DOH) launched today a hotline for reporting any complaints of drugs sold in the country.

Consumers may now report to the FDA any complaint or problem with their medicines to telephone # 807-8275, or text 090... or 0909-2080500, or email at ireport@bfad.gov.ph. Reports may also be made through the Bantay Gamot Report Forms available in most drugstores.

“In this age of globalization, consumerism, free trade, and increasing use of the internet, the ordinary person now has easy access to different drugs and medicines. Combine this with the penchant for self-medication and the need to improve the drug dispensing practices of our pharmacists and we have a potentially harmful situation where drug safety is questioned,” Health Secretary Francisco T. Duque III declared.

To address this situation, the FDA came up with the Medicines Surveillance Integrating Consumer Reporting Project in the National Capital Region which aims to educate consumers on the proper use of drugs and increase consumer awareness as to where to report complaints or problems with their medicines.

Previously, the FDA has received consumer reports that led to the detection of substandard drug preparations, adverse drug reactions and counterfeit medicines.

“These reports involved illegal business operation practices, such as operating without a license or a registered pharmacist, unlawful dispensing of drugs in the absence of a pharmacist, selling of unregistered drug products, or expired drugs, or suspected counterfeit drugs,” Duque explained.

Other reports were about errors in drug dispensing, common side effects of medicines, lack of drug efficacy, false claims of food supplements, and quality defects,” the health chief added.

“All reports will be treated as confidential and shall be analyzed and investigated following FDA protocol.” Duque assured.

In case of complaints against any drug, the caller may give his name, address, and contact numbers; however, in case of adverse drug reactions, the caller will be asked to give this information and other clinical data as needed.

“The FDA is committed to guard efficiently our nation’s drug supply and advocates patient care to protect the right to health of every Filipino,” Duque concluded.

No comments: